MedDataX Logo

Helicobacter Pylori Infection Among Women With Recurrent Abortion of Unknown Cause

NCT ID: NCT07293169

Last Updated: 2025-12-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-12-31

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

* Helicobacter pylori (H. pylori) infection affects approximately one half of the world population and it is more prevalent in developing countries. This microorganism colonizes the stomach. Typically, it is acquired during childhood and causes asymptomatic chronic infection. A small portion of H. pylori infected subjects develop peptic ulcers and gastric carcinoma, usually during late adulthood. (1,2)
* Some studies show a relationship between H.pylori and pregnancy-related disorders, such as fetal growth defects and malformations, miscarriage and, more recently, to pre-eclampsia. (3)
* Abortion is one of the most common complications of pregnancy. Infection is one of the main causes of abortion, a cause which is more important in spontaneous abortion; infections account for only 5% of recurrent abortions. (4)
* The severity of infection with H.pylori: given the increasing secretion of inflammatory cytokines and CD8 +, CD4 + in T cells and increasing interferons (IFN), studies have shown that infection with Helicobacter pylori activates immune cells in the uterus and endometrial surface cells, increases TH1 response to helicobacter, disturbs the ratio of T-Helper 2 / T-Helper 1 cytokines, causes abnormalities in the formation of natural vessels in the uterus and, ultimately, leads to abortion.(5)
* Repeated spontaneous abortion (RSA): \>=2 consecutive spontaneous pregnancy losses before 20 weeks gestation.(6)
* To determine if H.pylori infection is significantly associated with recurrent abortion of unknown cause........

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

3.Patients and methods

Study design:

Case Control study two groups (one group of 50 women with history of recurrent abortion and another group of 50 women without recurrent of abortion)

Study location:

the study will be conducted in Assiut university hospitals (women's health hospital) .

Study duration:

the study will be carried out from October 2025 till October 2026.

Sample size :

the calculated sample size for two groups 100 cases (one group of 50 women with history of recurrent abortion and another group of 50 women without recurrent of abortion).

4.Inclusion criteria

* All woman with repeated abortion of Unknwon cause.
* Not received H.pylori eradication therapy in prior 3 months .

5.Exclusion criteria
* Known uterine anatomical causes of abortion.
* Current systemic antibiotic use and PPIs within 2 weeks.
* Medical diseases as (Thyroid disorders , DM,HTN).
* Antiphspholipid syndrome. 6.Methods
* Case Control study at Assiut woman's heath hospital from October 2025 till October 2026.
* Case Control study two groups (one group of women with history of recurrent abortion and another group of women without recurrent of abortion) by stool antigen test.

7.All patients will be subjected to the following
* Complete obstetric history , medical history, smoking ,alcohol, recent antibiotics ,PPIs , socioeconomic status
* Laboratory samples :

H.pylori antigen in stool ,complete blood count , abdominopelvic ultrasound , urine analysis , liver and kidney function tests ,TSH , prolactin and any necessary investigation will be done.

Anti cardiolipin (IgM , IgG) ,Lupus anti coagulant and Anti B2 glycoproteinA1 (IgM, IgG) and 3D US on uterus . 8.Ethical considerations

* All subjects will provide written informed consent to participate in the study .
* The protocol of the study will be presented to the local ethics committee for approval.

9.Statistical analysis
* Statistical analysis will be performed using Spss version 23.

10.References
* 1\. Malaty HM. Epidemiology of Helicobacter pylori infection. Best Pract Res Clin Gastroenterol 2007; 21: 205-214
* 2\. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002; 347: 1175-1186
* 3\. Chen MJ, Fang YJ, Wu MS, Chen CC, Chen YN, Yu CC et al. Application of Helicobacter pylori stool antigen test to survey the updated prevalence of Helicobacter pylori infection in Taiwan. 2020;35:233-40
* 4\. Ambühl LM, Baandrup U, Dybkær K,Blaakær J, Uldbjerg N, Sørensen S. Human papillomavirus infection as a possible cause of spontaneous abortion and spontaneous preterm delivery 2016;2016.
* 5\. Azami M, Nasirkandy MP, Mansouri A, Darvishi Z, Rahmati S, Abangah G, DehghanHR, Borji M, Abbasalizadeh S. GGollobal Prevelance of H.pylori infection in pregnant women: a systematic review and meta-analysis study. Int J Women's Health Reprod Sci. 2017;5:30-6.
* 6\. Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril. 2013 99:63.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Helicobacter Pylori Infection, Susceptibility to

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

one group of women with history of recurrent abortion

another group of women without recurrent of abortion

H pylori eradication

Intervention Type DIAGNOSTIC_TEST

h.pylori stool antigen

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

H pylori eradication

h.pylori stool antigen

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Not received H.pylori eradication therapy in prior 3 months .

Exclusion Criteria

* Known uterine anatomical causes of abortion.
* Current systemic antibiotic use and PPIs within 2 weeks.
* Medical diseases as (Thyroid disorders , DM,HTN).
* Antiphspholipid syndrome.
Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mostafa Gamal Ahmed Mostafa

Helicobacter pylori infection among women with recurrent abortion of unknown cause

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mostafa Gamal Ahmed Mostafa موشا -مركز اسيوط -محافظة اسيوط

Role: CONTACT

Phone: 01095773806

Email: [email protected]

Hanan Mohamed Nafeh assiut

Role: CONTACT

Phone: 01003053369

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H.pylori infection e abortion

Identifier Type: -

Identifier Source: org_study_id